ALK Abell (Denmark) Today
| ALK-B Stock | DKK 155.70 2.00 1.27% |
PerformanceVery Weak
| Odds Of DistressLow
|
ALK Abell is trading at 155.70 as of the 27th of February 2025, a 1.27 percent down since the beginning of the trading day. The stock's open price was 157.7. ALK Abell has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
ALK-Abell AS, a pharmaceutical company, develops and markets products and services for allergy and allergic asthma in Europe, North America, and internationally. ALK-Abell AS was founded in 1923 and is headquartered in Hrsholm, Denmark. ALK Abell operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. The company has 200.74 M outstanding shares. More on ALK Abell AS
Moving against ALK Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ALK Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ALK Abell's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ALK Abell or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
ALK Abell AS (ALK-B) is traded on Copenhagen Exchange in Denmark and employs 2,680 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 24.3 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ALK Abell's market, we take the total number of its shares issued and multiply it by ALK Abell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ALK Abell AS operates under Healthcare sector and is part of Biotechnology industry. The entity has 200.74 M outstanding shares.
ALK Abell AS has accumulated about 375 M in cash with 416 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.47.
Check ALK Abell Probability Of Bankruptcy
Ownership AllocationALK Abell holds a total of 200.74 Million outstanding shares. Over half of ALK Abell's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Thus, these institutions are subject to different rules and regulations than regular investors in ALK Abell. Please watch out for any change in the institutional holdings of ALK Abell AS as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ALK Ownership Details
ALK Abell AS Risk Profiles
Although ALK Abell's alpha and beta are two of the key measurements used to evaluate ALK Abell's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.73 | |||
| Semi Deviation | 1.99 | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.86 |
ALK Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ALK Abell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
ALK Abell Corporate Management
Elected by the shareholders, the ALK Abell's board of directors comprises two types of representatives: ALK Abell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ALK. The board's role is to monitor ALK Abell's management team and ensure that shareholders' interests are well served. ALK Abell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ALK Abell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Soren Jelert | Ex CFO | Profile | |
| Carsten Hellmann | CEO Pres | Profile | |
| Miles Guralnick | Pres Inc | Profile | |
| Sren Jelert | Ex CFO | Profile | |
| Per Plotnikof | Investor Communications | Profile | |
| Christian Houghton | Head Supply | Profile | |
| Henrik Jacobi | Ex Management | Profile |
Other Information on Investing in ALK Stock
ALK Abell financial ratios help investors to determine whether ALK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALK with respect to the benefits of owning ALK Abell security.